巴西癌症学会关于在SUS范围内纳入Transtuzunabe- entanssin治疗Her-2阳性乳腺癌的意见

{"title":"巴西癌症学会关于在SUS范围内纳入Transtuzunabe- entanssin治疗Her-2阳性乳腺癌的意见","authors":"C. Santos, Enaldo Melo de Lima, R. Antunes","doi":"10.29327/258045.28.67-2","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":169828,"journal":{"name":"Revista da Sociedade Brasileira de Cancerologia","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Parecer da Sociedade Brasileira de Cancerologia Quanto a Incorporação de Transtuzunabe-entansina no Tratamento do câncer de mama Her-2 positivo no âmbito do SUS\",\"authors\":\"C. Santos, Enaldo Melo de Lima, R. Antunes\",\"doi\":\"10.29327/258045.28.67-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":169828,\"journal\":{\"name\":\"Revista da Sociedade Brasileira de Cancerologia\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista da Sociedade Brasileira de Cancerologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29327/258045.28.67-2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista da Sociedade Brasileira de Cancerologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29327/258045.28.67-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}